An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment

References

• Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685. doi:10.1001/jama.2021.0106
   PubMed Web of Science ®Google Scholar
• Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ. 2021;374:n1855. doi:10.1136/bmj.n1855
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-9
   PubMed Web of Science ®Google Scholar
• Robinson JR, Newcomb PA, Hardikar S, et al. Stage IV colorectal cancer primary site and patterns of distant metastasis. Cancer Epidemiol. 2017;48:92–95. doi:10.1016/j.canep.2017.04.003
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yuan H, Li Z, et al. Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data. Cancer Biol Med. 2021;18:175–186. doi:10.20892/j.issn.2095-3941.2020.0634
   Web of Science ®Google Scholar
• Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139–4147. doi:10.1002/cncr.32163
   PubMed Web of Science ®Google Scholar
• Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70–83. doi:10.1016/j.ejca.2018.12.019
   PubMed Web of Science ®Google Scholar
• Linnekamp JF, Wang X, Medema JP, et al. Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypes. Cancer Res. 2015;75(2):245–249. doi:10.1158/0008-5472.CAN-14-2240
   PubMed Web of Science ®Google Scholar
• Lieu CH, Corcoran RB, Overman MJ. Integrating biomarkers and targeted therapy into colorectal cancer management. Am Soc Clin Oncol Educ Book. 2019;39(39):207–215. doi:10.1200/EDBK_240839
   PubMedGoogle Scholar
• Bhullar DS, Barriuso J, Mullamitha S, et al. Biomarker concordance between primary colorectal cancer and its metastases. EBioMedicine. 2019;40:363–374. doi:10.1016/j.ebiom.2019.01.050
   PubMed Web of Science ®Google Scholar
• Nielsen MS, Axelsen LN, Sorgen PL et al. Gap junctions. Compr Physiol. 2012;2(3):1981–2035.
   PubMed Web of Science ®Google Scholar
• Beyer EC, Berthoud VM. Gap junction gene and protein families: connexins, innexins, and pannexins. Biochim Biophys Acta Biomembr. 2018;1860(1):5–8. doi:10.1016/j.bbamem.2017.05.016
   PubMed Web of Science ®Google Scholar
• Mao XY, Li -Q-Q, Gao Y-F, et al. Gap junction as an intercellular glue: emerging roles in cancer EMT and metastasis. Cancer Lett. 2016;381(1):133–137. doi:10.1016/j.canlet.2016.07.037
   PubMed Web of Science ®Google Scholar
• Bonacquisti EE, Nguyen J. Connexin 43 (Cx43) in cancer: implications for therapeutic approaches via gap junctions. Cancer Lett. 2019;442:439–444. doi:10.1016/j.canlet.2018.10.043
   PubMed Web of Science ®Google Scholar
• Thiagarajan PS, Sinyuk M, Turaga SM, et al. Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun. 2018;9(1):578. doi:10.1038/s41467-018-02938-1
   PubMed Web of Science ®Google Scholar
• Hulikova A, Black N, Hsia L-T, et al. Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid. Proc Natl Acad Sci USA. 2016;113(36):E5344–E5353. doi:10.1073/pnas.1610954113
   PubMed Web of Science ®Google Scholar
• Zhao S, Ye Z, Stanton R. Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols. Rna. 2020;26(8):903–909. doi:10.1261/rna.074922.120
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41(Database issue):D991–D995. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu H, Sun W, et al. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer. Gene. 2022;813:146117. doi:10.1016/j.gene.2021.146117
   PubMed Web of Science ®Google Scholar
• Ebadfardzadeh J, Kazemi M, Aghazadeh A, et al. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Med Oncol. 2021;38(9):114. doi:10.1007/s12032-021-01543-5
   PubMed Web of Science ®Google Scholar
• David CC, Jacobs DJ. Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol. 2014;1084:193–226.
   PubMedGoogle Scholar
• Hu JY, Wang Y, Tong X-M, et al. When to consider logistic LASSO regression in multivariate analysis? Eur J Surg Oncol. 2021;47(8):2206. doi:10.1016/j.ejso.2021.04.011
   PubMed Web of Science ®Google Scholar
• Koch A, Jeschke J, Van Criekinge W, et al. MEXPRESS update 2019. Nucleic Acids Res. 2019;47(W1):W561–W565. doi:10.1093/nar/gkz445
   PubMed Web of Science ®Google Scholar
• Colwill K, Gräslund S. A roadmap to generate renewable protein binders to the human proteome. Nat Methods. 2011;8(7):551–558. doi:10.1038/nmeth.1607
   PubMed Web of Science ®Google Scholar
• Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662–680. doi:10.1038/s41568-020-0285-7
   PubMed Web of Science ®Google Scholar
• Magaki S, Hojat SA, Wei B, So A, Yong WH. An introduction to the performance of immunohistochemistry. Methods Mol Biol. 2019;1897:289–298.
   PubMedGoogle Scholar
• Im K, Mareninov S, Diaz M, Yong WH. An introduction to performing immunofluorescence staining. Methods Mol Biol. 2019;1897:299–311.
   PubMedGoogle Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–d612. doi:10.1093/nar/gkaa1074
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH, Gorodkin J, et al. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–632. doi:10.1021/acs.jproteome.8b00702
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen S-H, Wu -H-H, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g: profiler, GSEA, Cytoscape and enrichment Map. Nat Protoc. 2019;14(2):482–517. doi:10.1038/s41596-018-0103-9
   PubMed Web of Science ®Google Scholar
• Kovacic B, Rosner M, Schlangen K, et al. DRUGPATH - a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs. Sci Rep. 2019;9(1):1897. doi:10.1038/s41598-018-37491-w
   PubMed Web of Science ®Google Scholar
• Cao Y, Jiao N, Sun T, et al. CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer. Front Cell Dev Biol. 2021;9:646252. doi:10.3389/fcell.2021.646252
   PubMed Web of Science ®Google Scholar
• Huang Z, Pan J, Wang H, et al. Prognostic significance and tumor immune microenvironment heterogenicity of m5C RNA methylation regulators in triple-negative breast cancer. Front Cell Dev Biol. 2021;9:657547. doi:10.3389/fcell.2021.657547
   PubMed Web of Science ®Google Scholar
• Hwang H, Cho G, Jung K, et al. An approach to structural equation modeling with both factors and components: integrated generalized structured component analysis. Psychol Methods. 2021;26(3):273–294. doi:10.1037/met0000336
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Chong W, Shang L, Liu J, et al. m 6 A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics. 2021;11(5):2201–2217. doi:10.7150/thno.52717
   PubMed Web of Science ®Google Scholar
• Pan JH, Zhou H, Cooper L, et al. LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers. Front Immunol. 2019;10:6. doi:10.3389/fimmu.2019.00006
   PubMed Web of Science ®Google Scholar
• Ma M, Dai J, Tang H, et al. MicroRNA-23a-3p inhibits mucosal melanoma growth and progression through targeting adenylate cyclase 1 and attenuating cAMP and MAPK pathways. Theranostics. 2019;9(4):945–960. doi:10.7150/thno.30516
   PubMed Web of Science ®Google Scholar
• Kawamura N, Takaoka K, Hamada H, et al. Rab7-mediated endocytosis establishes patterning of Wnt activity through inactivation of Dkk antagonism. Cell Rep. 2020;31(10):107733. doi:10.1016/j.celrep.2020.107733
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Hu JL, Wang W, Lan XL, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18(1):91. doi:10.1186/s12943-019-1019-x
   PubMed Web of Science ®Google Scholar
• Yang J, Qin G, Luo M, et al. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. Cell Death Dis. 2015;6(7):e1829. doi:10.1038/cddis.2015.197
   PubMed Web of Science ®Google Scholar
• Naus CC, Aftab Q, Sin WC. Common mechanisms linking connexin43 to neural progenitor cell migration and glioma invasion. Semin Cell Dev Biol. 2016;50:59–66. doi:10.1016/j.semcdb.2015.12.008
   PubMed Web of Science ®Google Scholar
• Xiang Y, Wang Q, Guo Y, et al. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):145. doi:10.1186/s13046-019-1142-y
   PubMed Web of Science ®Google Scholar
• Kotini M, Mayor R. Connexins in migration during development and cancer. Dev Biol. 2015;401(1):143–151. doi:10.1016/j.ydbio.2014.12.023
   PubMed Web of Science ®Google Scholar
• Czyż J, Szpak K, Madeja Z. The role of connexins in prostate cancer promotion and progression. Nat Rev Urol. 2012;9(5):274–282. doi:10.1038/nrurol.2012.14
   PubMed Web of Science ®Google Scholar
• Zeng SG, Lin X, Liu J-C, et al. Hypoxia‑induced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of non‑small cell lung cancer via the P53/MDM2 signaling pathway. Int J Oncol. 2019;55(4):845–859. doi:10.3892/ijo.2019.4867
   PubMed Web of Science ®Google Scholar
• Narayanapillai SC, Han YH, Song JM, et al. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis. Carcinogenesis. 2020;41(11):1518–1528. doi:10.1093/carcin/bgaa059
   PubMed Web of Science ®Google Scholar
• Borcoman E, De La Rochere P, Richer W, et al. Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer. Oncoimmunology. 2019;8(5):e1581556. doi:10.1080/2162402X.2019.1581556
   PubMed Web of Science ®Google Scholar
• Gong Z, Zhang J, Guo W. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer. Cancer Med. 2020;9(23):9052–9063. doi:10.1002/cam4.3505
   PubMed Web of Science ®Google Scholar
• Nelson TK, Sorgen PL, Burt JM. Carboxy terminus and pore-forming domain properties specific to Cx37 are necessary for Cx37-mediated suppression of insulinoma cell proliferation. Am J Physiol Cell Physiol. 2013;305(12):C1246–C1256. doi:10.1152/ajpcell.00159.2013
   PubMed Web of Science ®Google Scholar
• Morel S, Burnier L, Roatti A, et al. Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis. 2010;31(11):1922–1931. doi:10.1093/carcin/bgq170
   PubMed Web of Science ®Google Scholar
• Su YJ, Zhang J-X, Li S-M, et al. Relationship of vasculogenic mimicry, SphK1 expression, and Cx43 expression to metastasis and prognosis in colorectal cancer. Int J Clin Exp Pathol. 2018;11(11):5290–5299.
   PubMed Web of Science ®Google Scholar
• Gupta A, Chatree S, Buo AM, et al. Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts. Pflugers Arch. 2019;471(9):1235–1243. doi:10.1007/s00424-019-02295-y
   PubMed Web of Science ®Google Scholar
• Fostok S, El-Sibai M, Bazzoun D, et al. Connexin 43 loss triggers cell cycle entry and invasion in non-neoplastic breast epithelium: a role for noncanonical Wnt signaling. Cancers. 2019;11(3):339. doi:10.3390/cancers11030339
   PubMed Web of Science ®Google Scholar
• Loeuillard E, Yang J, Buckarma E, et al. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. J Clin Invest. 2020;130(10):5380–5396. doi:10.1172/JCI137110
   PubMed Web of Science ®Google Scholar
• Bu L, Baba H, Yoshida N, et al. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38(25):4887–4901. doi:10.1038/s41388-019-0765-y
   PubMed Web of Science ®Google Scholar
• Zhang R, Qi F, Zhao F, et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death Dis. 2019;10(4):273. doi:10.1038/s41419-019-1435-2
   PubMed Web of Science ®Google Scholar